168 related articles for article (PubMed ID: 37761849)
21. DNAJB1-PRKACA in HEK293T cells induces LINC00473 overexpression that depends on PKA signaling.
Kim SS; Kycia I; Karski M; Ma RK; Bordt EA; Kwan J; Karki A; Winter E; Aktas RG; Wu Y; Emili A; Bauer DE; Sethupathy P; Vakili K
PLoS One; 2022; 17(2):e0263829. PubMed ID: 35167623
[TBL] [Abstract][Full Text] [Related]
22. Integrated analysis of long noncoding RNA expression profiles in lymph node metastasis of hepatocellular carcinoma.
Ma J; Zhang L; Yang P; Zeng ZC; Xiang ZL
Gene; 2018 Nov; 676():47-55. PubMed ID: 29981417
[TBL] [Abstract][Full Text] [Related]
23. Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma.
Pan YF; Qin T; Feng L; Yu ZJ
J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):96-101. PubMed ID: 23392715
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of N
Zhu HX; Lu WJ; Zhu WP; Yu S
J Clin Lab Anal; 2021 Dec; 35(12):e24071. PubMed ID: 34741346
[TBL] [Abstract][Full Text] [Related]
25. The long noncoding RNA expression profile of hepatocellular carcinoma identified by microarray analysis.
Zhu J; Liu S; Ye F; Shen Y; Tie Y; Zhu J; Jin Y; Zheng X; Wu Y; Fu H
PLoS One; 2014; 9(7):e101707. PubMed ID: 25025236
[TBL] [Abstract][Full Text] [Related]
26. Characterization of differentially expressed and lipid metabolism-related lncRNA-mRNA interaction networks during the growth of liver tissue through rabbit models.
Wang G; Li M; Wang Y; Wang B; Pu H; Mao J; Zhang S; Zhou S; Luo P
Front Vet Sci; 2022; 9():998796. PubMed ID: 36118359
[TBL] [Abstract][Full Text] [Related]
27.
Kastenhuber ER; Lalazar G; Houlihan SL; Tschaharganeh DF; Baslan T; Chen CC; Requena D; Tian S; Bosbach B; Wilkinson JE; Simon SM; Lowe SW
Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13076-13084. PubMed ID: 29162699
[TBL] [Abstract][Full Text] [Related]
28. DNAJB1-PRKACA is specific for fibrolamellar carcinoma.
Graham RP; Jin L; Knutson DL; Kloft-Nelson SM; Greipp PT; Waldburger N; Roessler S; Longerich T; Roberts LR; Oliveira AM; Halling KC; Schirmacher P; Torbenson MS
Mod Pathol; 2015 Jun; 28(6):822-9. PubMed ID: 25698061
[TBL] [Abstract][Full Text] [Related]
29. DNAJB1-PRKACA-positive metastatic fibrolamellar carcinoma with unknown primary in a pediatric patient.
Balbeur S; Dumortier A; Mergen J; Libbrecht L; Torbenson M; Boulanger C; de Ville de Goyet M; Van Damme A; Brichard B
Pediatr Blood Cancer; 2020 Feb; 67(2):e28060. PubMed ID: 31736218
[TBL] [Abstract][Full Text] [Related]
30. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
[TBL] [Abstract][Full Text] [Related]
31. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
32. Analysis of long non-coding RNA expression profiles using RNA sequencing in ovarian endometriosis.
Cui D; Ma J; Liu Y; Lin K; Jiang X; Qu Y; Lin J; Xu K
Gene; 2018 Oct; 673():140-148. PubMed ID: 29920364
[TBL] [Abstract][Full Text] [Related]
33. RNA-Sequencing and Bioinformatics Analysis of Long Noncoding RNAs and mRNAs in the Prefrontal Cortex of Mice Following Repeated Social Defeat Stress.
Wang X; Ma S; Mao M; Li C; Shen X; Xu S; Yang J
Biomed Res Int; 2019; 2019():7505260. PubMed ID: 31032362
[TBL] [Abstract][Full Text] [Related]
34. Analysis of LncRNA-mRNA Co-Expression Profiles in Patients With Polycystic Ovary Syndrome: A Pilot Study.
Sun X; Liu Y; Gao X; Du M; Gao M; Zhong X; Wei X
Front Immunol; 2021; 12():669819. PubMed ID: 33936113
[TBL] [Abstract][Full Text] [Related]
35. DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma.
Kirk AM; Crawford JC; Chou CH; Guy C; Pandey K; Kozlik T; Shah RK; Chung S; Nguyen P; Zhang X; Wang J; Bell M; Mettelman RC; Allen EK; Pogorelyy MV; Kim H; Minervina AA; Awad W; Bajracharya R; White T; Long D; Gordon B; Morrison M; Glazer ES; Murphy AJ; Jiang Y; Fitzpatrick EA; Yarchoan M; Sethupathy P; Croft NP; Purcell AW; Federico SM; Stewart E; Gottschalk S; Zamora AE; DeRenzo C; Strome SE; Thomas PG
Cell Rep Med; 2024 Mar; 5(3):101469. PubMed ID: 38508137
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of long non‑coding RNA‑messenger RNA‑microRNA co‑expression network identifies cell cycle‑related lncRNA in hepatocellular carcinoma.
Zhu HR; Yu XN; Zhang GC; Shi X; Bilegsaikhan E; Guo HY; Liu LL; Cai Y; Song GQ; Liu TT; Dong L; Janssen HLA; Weng SQ; Wu J; Shen XZ; Zhu JM
Int J Mol Med; 2019 Nov; 44(5):1844-1854. PubMed ID: 31485608
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide analysis of long noncoding RNA (lncRNA) expression in hepatoblastoma tissues.
Dong R; Jia D; Xue P; Cui X; Li K; Zheng S; He X; Dong K
PLoS One; 2014; 9(1):e85599. PubMed ID: 24465615
[TBL] [Abstract][Full Text] [Related]
38. Novel protein kinase cAMP-Activated Catalytic Subunit Alpha (PRKACA) inhibitor shows anti-tumor activity in a fibrolamellar hepatocellular carcinoma model.
Toyota A; Goto M; Miyamoto M; Nagashima Y; Iwasaki S; Komatsu T; Momose T; Yoshida K; Tsukada T; Matsufuji T; Ohno A; Suzuki M; Ubukata O; Kaneta Y
Biochem Biophys Res Commun; 2022 Sep; 621():157-161. PubMed ID: 35839742
[TBL] [Abstract][Full Text] [Related]
39. β-catenin cancer-enhancing genomic regions axis is involved in the development of fibrolamellar hepatocellular carcinoma.
Gulati R; Johnston M; Rivas M; Cast A; Kumbaji M; Hanlon MA; Lee S; Zhou P; Lake C; Schepers E; Min KW; Yoon JH; Karns R; Reid LM; Lopez-Terrada D; Timchenko L; Parameswaran S; Weirauch MT; Ranganathan S; Bondoc A; Geller J; Tiao G; Shin S; Timchenko N
Hepatol Commun; 2022 Oct; 6(10):2950-2963. PubMed ID: 36000549
[TBL] [Abstract][Full Text] [Related]
40. A genomic case study of mixed fibrolamellar hepatocellular carcinoma.
Griffith OL; Griffith M; Krysiak K; Magrini V; Ramu A; Skidmore ZL; Kunisaki J; Austin R; McGrath S; Zhang J; Demeter R; Graves T; Eldred JM; Walker J; Larson DE; Maher CA; Lin Y; Chapman W; Mahadevan A; Miksad R; Nasser I; Hanto DW; Mardis ER
Ann Oncol; 2016 Jun; 27(6):1148-1154. PubMed ID: 27029710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
